Abstract:Background: Blood purification therapy for patients overloaded with metabolic toxins or drugs still needs improvement. Blood purification therapies, such as in hemodialysis or peritoneal dialysis can profit from a combined application with nanoparticles. Summary: In this review, the published literature is analyzed with respect to nanomaterials that have been customized and functionalized as nano-adsorbents during blood purification therapy. Liposomes possess a distinct combined structure composed of a hydrophobic lipid bilayer and a hydrophilic core. The liposomes which have enzymes in their aqueous core or obtain specific surface modifications of the lipid bilayer can offer appreciated advantages. Preclinical and clinical experiments with such modified liposomes show that they are highly efficient and generally safe. They may serve as indirect and direct adsorption materials both in hemodialysis and peritoneal dialysis treatment for patients with renal or hepatic failure. Apart from dialysis, nanoparticles made of specially designed metal and activated carbon have also been utilized to enhance the removal of solutes during hemoadsorption. Results are a superior adsorption capacity and good hemocompatibility shown during the treatment of patients with toxication or end-stage renal disease. In summary, nanomaterials are promising tools for improving the treatment efficacy of organ failure or toxication. Key messages: (i) The pH-transmembrane liposomes and enzyme-loaded liposomes are two representatives of liposomes with modified aqueous inner core which have been put into practice in dialysis. (ii) Unmodified or physiochemically modified liposomal bilayers are ideal binders for lipophilic protein-bound uremic toxins or cholestatic solutes, thus liposome-supported dialysis could become the next-generation hemodialysis treatment of artificial liver support system. (iii) Novel nano-based sorbents featuring large surface area, high adsorption capacity and decent biocompatibility have shown promise in the treatment of uremia, hyperbilirubinemia, intoxication, and sepsis. (vi) A major challenge of production lies in avoiding changes in physical and chemical properties induced by manufacturing and sterilizing procedures.

A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients

P1101A Bifunctional Adsorber Particle For The Removal Of Hydrophobic Uremic Toxins From Whole Blood Of Renal Failure Patients

Zwitterionic Polymers As High-Performance Coatings for Hemoperfusion Adsorbents and Their Chemisorption of Protein-Bound Toxins Through Computational Simulations

In vitro Removal of Protein-Bound Retention Solutes by Extracorporeal Blood Purification Procedures

A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis

Designing adsorptive membranes for removing protein-bound uremic toxins via π-π and cation-π interaction

Adsorption-based strategies for removing uremic toxins from blood

In vitro Removal of Therapeutic Drugs with a Novel Adsorbent System

Adsorption capacity of poly(ether imide) microparticles to uremic toxins

Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro

Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis

Progress in Hemoperfusion Adsorbents of Common Toxins in Liver and Kidney Failure

Rationale for Adsorption in Extracorporeal Blood Purification

Application of Nanoparticles as Novel Adsorbents in Blood Purification Strategies

Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives

Adsorption Dynamics of Uremic Toxins to Cyclodextrin-Coated Magnetic Nano-Adsorbents

Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique

Protein/Polysaccharide Composite towards Multi‐in‐one Toxin Removal in Blood with Self‐anticoagulation and Biocompatibility

Use of Combined Hemodialysis/Hemoperfusion in Chronic Uremia1

Increasing the Removal of Protein-Bound Uremic Toxins by Liposome-Supported Hemodialysis.

Hemocompatibility of Albumin-Modified Magnetic Nanoparticles